Need for the Development of Clinical and Translational Science Institutes in India

Volume 4, Jul 2015

Gundu H. R. Rao, Prashanth T. Rao, Jigna Sheth, Bengaluru, India; Manchester, England

There is considerable interest among researchers, clinicians and policy makers, for developing early biomarkers, both for genetic and molecular diagnosis and using them for clinical studies. According to National Cancer Institute (NCI) of the National Institutes of Health (NIH), USA, one of the most widely recognized roadblock to progress in cancer research is the lack of standardized, high-quality biospecimens. If a State-of-the-art bio-repository were established in India, with international protocols, and NCI best practices procedures in place, it would provide a wealth of standardized clinical samples for all kinds of studies. The genetic diversity as well as cancer diversity in India is huge. We see a lot of collaborative projects spawning from such a platform.

Volume 4, Number 3, Pages: 66-75